Two Sigma Investments
QTTB icon

Two Sigma Investments’s Q32 Bio QTTB Stock Holding History

Two Sigma Investments’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$272K Sell
42,346
-4,479
-10% -$21.3K ﹤0.01% 4131
2025
Q4 		$155K Buy
46,825
+15,319
+49% +$43.3K ﹤0.01% 3800
2025
Q3 		$62.4K Buy
+31,506
New +$60.5K ﹤0.01% 3522
2025
Q1 		– Sell
-53,175
Closed -$183K – 3539
2024
Q4 		$183K Buy
+53,175
New +$1.68M ﹤0.01% 2889
2022
Q4 		– Sell
-584
Closed -$17K – 3118
2022
Q3 		$17K Buy
+584
New +$23.8K ﹤0.01% 2388
2022
Q1 		– Sell
-4,352
Closed -$285K – 4554
2021
Q4 		$285K Sell
4,352
-4,600
-51% -$446K ﹤0.01% 3682
2021
Q3 		$1.27M Buy
+8,952
New +$1.14M ﹤0.01% 2393
2020
Q2 		– Sell
-923
Closed -$258K – 3620
2020
Q1 		$258K Buy
+923
New +$283K ﹤0.01% 2444
2019
Q3 		– Sell
-2,533
Closed -$892K – 3860
2019
Q2 		$892K Buy
+2,533
New +$995K ﹤0.01% 2035

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments's QTTB Position: Q1 2026 in Review

Two Sigma Investments reduced its Q32 Bio (QTTB) stake by 9.6% in Q1 2026, selling an estimated $21.3K and leaving 42,346 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #4131.

Two Sigma Investments first reported a position in QTTB in Q2 2019 and has held it in 9 quarters since. The position peaked at $1.27M in Q3 2021. 54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

  • Two Sigma Investments held 42,346 shares of Q32 Bio worth $272K as of Q1 2026.
  • Two Sigma Investments sold 4,479 Q32 Bio shares in Q1 2026, an estimated $21.3K.
  • Q32 Bio made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4131 holding.
  • Two Sigma Investments first reported a position in Q32 Bio in Q2 2019 and has held it in 9 quarters since.
  • Two Sigma Investments's Q32 Bio position peaked at $1.27M in Q3 2021.
  • 54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.